Status:
UNKNOWN
Stroke Prevention in Atrial Fibrillation Patients Between 2004 and 2020
Lead Sponsor:
Jan Kochanowski University
Conditions:
Atrial Fibrillation; Stroke Prevention
Eligibility:
All Genders
18+ years
Brief Summary
Prevention of thromboembolic complications is an important part in the management of patients with atrial fibrillation (AF). European and American guidelines recommend the use of non-vitamin K antagon...
Eligibility Criteria
Inclusion
- \- non-valvular atrial fibrillation
Exclusion
- valvular atrial fibrillation
- death during hospitalization
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04686045
Start Date
January 1 2021
End Date
May 1 2021
Last Update
January 26 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
1st Clinic of Cardiology and Electotherapy
Kielce, Grunwaldzka 45, Poland, 25-637
2
Iwona Gorczyca
Kielce, Poland, 25-525